Peter Hébert, Lux Capital co-founder and managing partner
Newcomer via YouTube
Deep-tech VC Lux Capital announced it closed a $1.5 billion vehicle Wednesday to invest in “the people turning sci-fi into sci-fact.”
In addition to a fresh cash infusion—a record high for the early-stage firm—ready to deploy, Lux could also see a sizable stream of exits in 2026, especially if the IPO window stays open.
Among its top prospects to go public are weapons manufacturer Anduril, data behemoth Databricks and payments platform provider Ramp, all of which have an 97% probability of an IPO, per PitchBook’s Exit Predictor.
“Our most meaningful and, from a position of [fair market value], the largest positions that we have across the funds could all go public tomorrow,” said Peter Hébert, managing partner at Lux, “it’s reflective of overall private markets that a lot of the entrepreneurs haven’t felt the need.”
Lux’s success has defied the troubled times for early-stage funds, thanks to its long history of making early bets on hardware and defense tech, which are now receiving widespread investor interest.
Lux is also one of a small cohort of blue-chip VC firms that straddle the divide between tech investing and biotech investing. It first invested in Resilience in 2020 at a $1.6 billion valuation, only for the biomedical startup’s valuation to quintuple less than three years later.
Latest Research
European VC Valuations Report
Lux has made similar early investments in biotech companies Eikon Therapeutics, Enveda and Kallyope, all before their valuations reached $1 billion. Biotech IPOs were relatively muted in 2025, but remain a potential hedge for venture capitalists given that sector’s listings and equities have their own market dynamics, separate from other tech IPOs.
In 2025, Lux had several headline exits including Chronosphere, acquired by Nasdaq-listed Palo Alto Networks in November for $3.3 billion, and Matterport, bought by CoStar Group for $2 billion in February.
Many VCs have opened continuation vehicles or run secondary sales to free up more liquidity for LPs—but not Lux.
“It’s not something we felt any pressure to do, and we have no intention to in the near term,” said Hébert.
But 2026 has only just begun, and views are mixed on whether IPOs will pick up this year. Much will hinge on macroeconomic factors, including rising inflation and stubbornly high interest rates.
How the AI market fares is also an open question, having driven much of the public market gains in 2025. Lux is heavily invested in AI companies, including Physical Intelligence, Hugging Face and Together AI.
Lux Capital’s last two flagship funds, raised in 2021 and 2023, recorded top-quartile IRRs in data reported by the Texas County & District Retirement System and New Mexico State Investment Council.
Learn about our editorial standards.